Global Stem Cell Assay (Viability, Purification, Identification) Market, 2018-2023 by Cell Type, Product & Service, Application & End User - ResearchAndMarkets.com

DUBLIN--()--The "Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The stem cell assay market is expected to reach USD 1,978.7 million by 2023 from USD 791.9 million in 2018, at a CAGR of 20.1%

The availability of funding for stem cell research; rising incidence of target indications; technological advancements in stem cell research instruments and the introduction of novel stem cell products; and the growth of end-use industries are the major factors driving the growth of this market. On the other hand, ethical issues related to embryonic stem cell research and the high cost of stem cell analysis instruments and reagents are factors expected to restrain the growth of this market to a certain extent.

Market report Highlights

  • The isolation & purification segment is estimated to grow at the highest rate during the forecast period. The rising demand for stem cell isolation assays in biotechnology and biopharmaceutical companies for drug development processes is driving the growth of this segment.
  • The biopharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. Stem cell assays are widely used by biopharmaceutical & biotechnology companies for drug screening and development and cell analysis, which is the key factor driving the growth of this end-user segment in this market.
  • In 2017, the stem cell assay market was dominated by North America; and also estimated to grow at the Highest growth rate during the forecast period. The growth of this segment can be attributed to the increasing availability of grants and funding from governments as well as the rising use of stem cells for personalized medicine and drug discovery & development.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Stem Cell Assays Market, By Type

7 Stem Cell Assays Market, By Cell Type

8 Stem Cell Assays Market, By Product & Service

9 Stem Cell Assays Market, By Application

10 Stem Cell Assays Market, By End User

11 Global Stem Cell Assays Market, By Region

12 Competitive Landscape

13 Company Profiles

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cell Biolabs
  • Cellular Dynamics International (CDI)
  • GE Healthcare
  • Hemogenix
  • Merck
  • Miltenyi Biotec
  • Perkinelmer
  • Promega Corporation
  • Stemcell Technologies
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/vk3d9m/global_stem_cell?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells